A New Alliance: Can a DEA and Community Partnership Turn the Tide on Fentanyl?

ALEXANDRIA, VA – June 04, 2026 – In a move signaling a significant strategic shift, the Drug Enforcement Administration (DEA) is preparing to convene its inaugural Fentanyl Free America Summit next month in Orlando, Florida. The event, however, is not a unilateral law enforcement operation. It is being built in partnership with the Community Anti-Drug Coalitions of America (CADCA), a veteran organization in the substance misuse prevention field, and will be co-located with CADCA’s 25th Annual Mid-Year Training Institute.

This joint venture aims to construct a unified front against a crisis that continues to claim tens of thousands of American lives. Preliminary CDC data predicts over 70,000 drug overdose deaths for the 12-month period ending last November, with illicitly manufactured fentanyl being the primary culprit. With an expected attendance of over 2,500 leaders from public health, law enforcement, education, and community organizations, the summit represents one of the most ambitious multi-sector mobilizations to date. The core question is whether this new architecture of collaboration can succeed where siloed efforts have fallen short.

Building a Unified Command

The summit is the public-facing centerpiece of the DEA’s broader “Fentanyl Free America” campaign, an initiative structured around three pillars: Protect, Prevent, and Support. While the “Protect” pillar continues the agency’s traditional and aggressive enforcement against trafficking networks—resulting in the seizure of over 47 million counterfeit pills in 2025 alone—this partnership with CADCA heavily emphasizes the “Prevent” and “Support” components.

“Fentanyl Free America is a national call to action to confront the deadliest drug threat our nation has ever faced,” said DEA Administrator Terrance C. Cole in the official announcement. He stressed that the summit is about strengthening partnerships and coordinating action, stating, “Ending this crisis requires all of us working together.”

This sentiment is echoed by CADCA, which brings an extensive grassroots network to the table. “CADCA, and our scores of prevention coalitions, stand proudly with DEA in the shared purpose of protecting communities from fentanyl poisoning,” said CADCA President and CEO General Barrye L. Price, Ph.D. He called the joint conference a “defining moment for the prevention field.”

The agenda for the week-long event is designed to move beyond rhetoric, providing attendees with training and networking opportunities to forge concrete, localized strategies. The goal is to create a “whole-of-nation response” that integrates the DEA’s intelligence on supply chains with CADCA’s expertise in community-level prevention.

The Community Coalition Engine

The DEA’s decision to contract with CADCA is a strategic one, rooted in the latter’s proven model for mobilizing communities. For over three decades, CADCA has built a network of more than 7,000 coalitions by equipping local leaders with an evidence-based toolkit known as the Strategic Prevention Framework (SPF). This framework guides communities through assessing their specific needs, building capacity, implementing targeted interventions, and evaluating their results.

The effectiveness of this model is not merely anecdotal. A multinational evaluation by the University of Texas found that CADCA-trained coalitions were twice as likely to reduce local drug access and 2.7 times more likely to reduce crime, yielding a significant return on investment. Case studies from coalitions participating in the Drug-Free Communities (DFC) program, many of which use CADCA’s training, report dramatic declines in youth substance use over the past decade.

By partnering with CADCA, the DEA is tapping into a pre-existing, highly functional engine for social change. CADCA’s training institutes are known for their practical impact; 98% of attendees at its 2025 Mid-Year event reported that the training was useful. This partnership allows federal strategy to be translated and adapted by trusted local leaders—from teachers and faith leaders to business owners and parents—who understand their community’s unique challenges.

A Contentious Pivot Beyond Enforcement

While the summit is being hailed as a landmark collaboration, it also takes place against a backdrop of intense debate over the direction of U.S. drug policy. For many public health and harm reduction advocates, law enforcement-led initiatives, even collaborative ones, carry the baggage of the decades-long “War on Drugs,” which they argue has failed to curb overdose deaths while fueling mass incarceration and racial disparities.

“We cannot arrest our way out of a public health crisis,” commented one public health researcher, speaking on the condition of anonymity. “While collaboration is always welcome, the focus must be on evidence-based health services, not just enforcement. People need treatment and support, not a jail cell.”

Critics point to the fact that while overall overdose deaths have seen a recent and welcome decline, the crisis continues to devastate specific populations, with Black and Indigenous Americans experiencing disproportionately high fatality rates. Harm reduction organizations argue that a truly comprehensive strategy must fully embrace measures that are sometimes viewed as controversial, such as expanding access to naloxone, fentanyl test strips, and syringe services programs. These interventions are backed by decades of evidence showing they save lives, reduce disease transmission, and can serve as a bridge to treatment.

The DEA’s own data shows a complex picture. While massive seizures of fentanyl may disrupt supply lines, they also highlight the sheer scale of the trafficking problem. The agency’s pivot toward a more holistic approach with its “Fentanyl Free America” campaign and this summit may be an acknowledgment that enforcement alone is an insufficient tool. The challenge for the DEA will be to prove that this is a genuine, long-term strategic evolution and not simply a public relations effort layered on top of a traditional enforcement-first model.

Mobilizing for Measurable Impact

The logistical and financial commitment to the Orlando summit is substantial. The DEA has directly contracted with CADCA, and attendee fees for the week range from over $700 for federal employees to more than $1,200 for non-member attendees, demonstrating a significant investment from all sectors. The event's deliverables are focused on creating actionable change and scalable models.

A key feature will be the inaugural “Fentanyl Free America Awards,” designed to recognize and promote innovative and effective programs from across the country. By highlighting what works—whether in law enforcement, prevention, or community support—the summit aims to create a library of best practices that can be replicated nationwide. The gathering is not just about discussion; it is about equipping an army of 2,500 community leaders with the strategies, partnerships, and unified messaging needed to return home and make a measurable impact.